The ANAscreen is a semi-quantitative immunoassay for the determination of IgG antibodies against nuclear and cytoplasmic antigens in human serum. The ANAscreen is intended as an aid in the diagnosis of systemic autoimmune disorders in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
4010 – ANAscreen
Autoimmunity, Diagnostics, ELISA
4010 – ANAscreen
Enzyme immunoassay for the semi-quantitative determination of IgG antibodies against nuclear and cytoplasmic antigens in human serum
Available Downloads:
| Indication | Systemic autoimmune diseases |
|---|---|
| Format | Microtiter plate coated with HeLa nuclei and enriched with recombinant and native antigens |
| Total incubation time | 105 min. |
| No. of determinations | 96 (93 x 1) + 1 x Calibrators + 2 x Controls |
Related products
-
3850 – Anti-GP2 IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against glycoprotein 2 in human serum
-
3750 – Anti-GP2 IgA
Enzyme immunoassay for the quantitative determination of IgA antibodies against glycoprotein 2 (GP2) in human serum
-
3102 – Medizym® anti-Tg
Enzyme immunoassay for the quantitative determination of IgG antibodies against thyroglobulin (Tg) in human serum